Cott (TSE:PRM – Get Free Report) was upgraded by equities research analysts at William Blair to a “strong-buy” rating in a research report issued on Thursday, Zacks.com reports.
Separately, Raymond James lowered shares of Cott from a “moderate buy” rating to a “hold” rating in a research note on Wednesday, October 2nd.
View Our Latest Analysis on Cott
Cott Stock Up 0.1 %
About Cott
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Recommended Stories
- Five stocks we like better than Cott
- The Basics of Support and Resistance
- Texas Roadhouse Stock Steering for New Highs This Year
- Airline Stocks – Top Airline Stocks to Buy Now
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Stock Market Sectors: What Are They and How Many Are There?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Cott Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cott and related companies with MarketBeat.com's FREE daily email newsletter.
